Evidence map›Paper›PMID 31952280›Full record

Trial reportNutrients2020

Lactobacillus reuteri DSM 17938 and Magnesium Oxide in Children with Functional Chronic Constipation: A Double-Blind and Randomized Clinical Trial.

Megumi Kubota, Kazuya Ito, Kazuhiko Tomimoto, Mitsuharu Kanazaki, Kei Tsukiyama, Akio Kubota, Haruo Kuroki, Mitsugu Fujita, Yvan Vandenplas

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 5 pooled it
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 5 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Probiotics for treatment of chronic constipation in children.The Cochrane database of systematic reviews · 2022
    Pooled it
  6. Lactoferrin combined withFrontiers in pediatrics · 2026
    Trial
  7. Trial
  8. Adjunctive efficacy of Bifidobacterium animalis subsp. lactis XLTG11 for functional constipation in children.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Trial
  9. Trial
  10. Review
  11. Article
  12. The Aging Gut-Brain Axis: Effects of Dietary Polyphenols and Metal Exposure.Chronic diseases and translational medicine · 2025
    Review
  13. Gut microbes · 2025
    Review
  14. Article
  15. Article
  16. Journal of traditional and complementary medicine · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Megumi KubotaKubota Children's Clinic, 2-6-18 Katsuyamakita Ikunoku, Osaka, 544-0033, Japan.
Kazuya ItoDepartment of Public Health, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi Abenoku, Osaka, 545-0051, Japan.
Kazuhiko TomimotoTomimoto Pediatric Clinic, 6-6-20 Minatotakadai, Hachinohe, 031-0823, Japan.
Mitsuharu KanazakiKanazaki Children's Clinic, 3323 Dotocho Nakaku, Sakai, 599-8234, Japan.
Kei TsukiyamaTsukiyama Child Care Clinic, 484 Akizuki, Wakayama, 640-8322, Japan.
Akio KubotaTsukiyama Child Care Clinic, 484 Akizuki, Wakayama, 640-8322, Japan.
Haruo KurokiSotobo Children's Clinic, 1880-4 Izumi Misakicho, Isumi, 299-4503, Japan.
Mitsugu FujitaDepartment of Microbiology, Kindai University Faculty of Medicine, 377-2 Ohnohigashi, Osakasayama,589-8511, Japan.
Yvan VandenplasKidZ Health Castle, UZ Brussel, Vrije Universiteit Brussel, 1090 Brussels, Belgium.
Akebono Clinic · JPKindai University · JPKubota (Japan) · JPOsaka City University · JPVrije Universiteit Brussel · BE

Funding

BioGaia CSUB0131
6 · The paper itself

Abstract

objectiveChronic functional constipation is a frequent condition. The aim of the study was to evaluate the efficacy of the probiotic Lactobacillus (L.) reuteri DSM 17938 and magnesium oxide (MgO) for relieving chronic functional constipation in children. STUDY

designA prospective, double-blind, placebo-controlled, randomized, and parallel-group trial was conducted in five pediatric outpatient clinics in Japan. Sixty patients who were more than six months old and under six years of age with a diagnosis of functional constipation according to Rome IV criteria were randomly divided into three groups: group A (n = 20) received L. reuteri DSM 17938 and lactose hydrate as a placebo of MgO; group B (n = 19) received L. reuteri DSM 17938 and MgO; and group C (n = 21) received a placebo of L. reuteri DSM 17938 and MgO.

resultsAll three groups exhibited significant improvement in defecation frequency in the fourth week compared with the baseline condition (group A: p < 0.05; group B: p < 0.05; group C: p < 0.05). The MgO group and combination group showed a significant decrease in stool consistency, but the L. reuteri DSM 17938 group did not (group A: p = 0.079; group B: p < 0.05; group C: p < 0.05). MgO significantly suppressed the presence of the genus Dialister. Defecation frequency negatively correlated with the frequency of Clostridiales-belonging bacteria among the gut microbiome.

conclusionsL. rueteri DSM 17938 and MgO were both effective in the management of functional constipation in young children. MgO caused an imbalance in the gastrointestinal microbiome, which was not the case in the probiotic group.

Indexed as

AntacidsChild, PreschoolChronic DiseaseConstipationDouble-Blind MethodFemaleHumansInfantLimosilactobacillus reuteriMagnesium OxideMaleProbioticsAntacidsMagnesium OxideBristol stool scaleconstipationDialisterfunctional gastrointestinal disorderLactobacillusmagnesium oxidemicrobiome

Identifiers

PMID31952280
PMCPMC7019518
OpenAlexW2999367391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.